[Analysis of associations between molecular subtypes and responses to neoadjuvant chemotherapy in primary breast cancer patients].
Yijun Zhou(Ministry of Education), Tao Ouyang(Peking University), Tie Fan, Jinfeng Li(Hebei Medical University), Zhaoqing Fan(Daqing Oilfield General Hospital), Tianfeng Wang(Peking University), Aiping Lu(University of Pittsburgh), Yiqiang Liu(Peking University), Min Ying(Peking University), Yingjian He(Peking University)
PubMed
June 11, 2013
Cited by 2
Related Papers
Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients
|Clinical Cancer Research|2017|272
Triazole–Dithiocarbamate Based Selective Lysine Specific Demethylase 1 (LSD1) Inactivators Inhibit Gastric Cancer Cell Growth, Invasion, and Migration
|Journal of Medicinal Chemistry|2013|221
Expression of ER-α36, a Novel Variant of Estrogen Receptor α, and Resistance to Tamoxifen Treatment in Breast Cancer
|Journal of Clinical Oncology|2009|218
A Systematic Review of Histone Lysine‐Specific Demethylase 1 and Its Inhibitors
|Medicinal Research Reviews|2015|181